Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

471 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group.
Miyawaki S, Tanimoto M, Kobayashi T, Minami S, Tamura J, Omoto E, Kuriyama K, Hatake K, Saito K, Kanamaru A, Oh H, Ohtake S, Asou N, Sakamaki H, Yamada O, Jinnai I, Tsubaki K, Takeyama K, Hiraoka A, Matsuda S, Takahashi M, Shimazaki C, Adachi K, Kageyama S, Ohno R, et al. Miyawaki S, et al. Among authors: hatake k. Int J Hematol. 1999 Aug;70(2):97-104. Int J Hematol. 1999. PMID: 10497848 Clinical Trial.
Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled study.
Ohno R, Miyawaki S, Hatake K, Kuriyama K, Saito K, Kanamaru A, Kobayashi T, Kodera Y, Nishikawa K, Matsuda S, Yamada O, Omoto E, Takeyama H, Tsukuda K, Asou N, Tanimoto M, Shiozaki H, Tomonaga M, Masaoka T, Miura Y, Takaku F, Ohashi Y, Motoyoshi K. Ohno R, et al. Among authors: hatake k. J Clin Oncol. 1997 Aug;15(8):2954-65. doi: 10.1200/JCO.1997.15.8.2954. J Clin Oncol. 1997. PMID: 9256140 Clinical Trial.
Therapy-related leukemia with a novel 21q22 rearrangement.
Izumi T, Ohtsuki T, Ohya K, Ogawa Y, Yoshida M, Muroi K, Imagawa S, Hatake K, Kuriki K, Saito K, Miura Y. Izumi T, et al. Among authors: hatake k. Cancer Genet Cytogenet. 1996 Aug;90(1):45-8. doi: 10.1016/0165-4608(96)00044-1. Cancer Genet Cytogenet. 1996. PMID: 8780746
Adult T cell leukemia lymphoma (ATL) localized in the right tibial bone.
Tabata M, Takahashi H, Izumi T, Komatsu N, Tsunoda J, Yoshida M, Nakama S, Kuriki K, Saito K, Hatake K, Miura Y. Tabata M, et al. Among authors: hatake k. Leuk Lymphoma. 1999 Sep;35(1-2):189-92. doi: 10.3109/10428199909145718. Leuk Lymphoma. 1999. PMID: 10512176 Review.
CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy.
Ennishi D, Takeuchi K, Yokoyama M, Asai H, Mishima Y, Terui Y, Takahashi S, Komatsu H, Ikeda K, Yamaguchi M, Suzuki R, Tanimoto M, Hatake K. Ennishi D, et al. Among authors: hatake k. Ann Oncol. 2008 Nov;19(11):1921-6. doi: 10.1093/annonc/mdn392. Epub 2008 Jun 23. Ann Oncol. 2008. PMID: 18573805 Free article.
471 results